Phase 3 Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with major depression (either currently or in a recent episode that has improved), with depression symptoms up to a moderate level based on a standard rating scale
- People whose depression is accompanied by noticeable thinking or memory difficulties, as measured by a specific cognitive test
- People who are also experiencing difficulties with day-to-day functioning, such as work, social activities, or self-care, as measured by a standard functional assessment scale
Who may not be able to join:
- People with an IQ below 85
- People with an unstable or poorly managed physical health condition that could affect thinking or memory test results
- People who have taken any of the following medications in the last 4 weeks: steroid medicines (glucocorticoids), probiotics, anti-inflammatory painkillers (such as ibuprofen), certain cholesterol medicines (bile acid sequestrants), immune-suppressing drugs, antihistamines, mast cell stabilisers, or antioxidant supplements
- People who have taken antibiotic medicines (taken by mouth or injection, affecting the whole body) in the last 2 months
- People who have had another diagnosed mental health condition (other than a personality disorder or nicotine use) in the last 3 months
- People with bipolar disorder who have experienced a manic or mixed mood episode in the last 3 months
- People whose depression meets the criteria for severe treatment-resistant depression (confirm with trial site)
- People who have received electroconvulsive therapy (ECT) within the past year
- People who have been receiving another structured psychological therapy programme in the 3 months before the study
- People who do not have access to a computer or tablet and a reliable internet connection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Maria J Portella, Dr, Institut de Recerca Sant Pau
Phone: +34935537791
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Functioning Assessment Short Test (FAST)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.